USANA Health Sciences (NYSE:USNA - Get Free Report) issued its quarterly earnings data on Tuesday. The company reported $0.73 earnings per share for the quarter, beating the consensus estimate of $0.70 by $0.03, Zacks reports. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. The company had revenue of $249.54 million for the quarter, compared to analyst estimates of $243.08 million. During the same period in the prior year, the firm earned $0.86 earnings per share. USANA Health Sciences updated its FY 2025 guidance to 2.350-3.000 EPS.
USANA Health Sciences Stock Performance
Shares of NYSE USNA traded down $0.03 during mid-day trading on Friday, reaching $27.07. The company had a trading volume of 295,874 shares, compared to its average volume of 122,357. The firm has a market cap of $510.54 million, a price-to-earnings ratio of 9.57, a PEG ratio of 0.93 and a beta of 1.00. The business's 50-day simple moving average is $27.85 and its 200 day simple moving average is $33.19. USANA Health Sciences has a one year low of $23.10 and a one year high of $49.78.
Analyst Upgrades and Downgrades
Several research firms recently issued reports on USNA. StockNews.com downgraded USANA Health Sciences from a "strong-buy" rating to a "buy" rating in a research note on Friday, February 14th. Sidoti cut shares of USANA Health Sciences from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, February 18th. Finally, DA Davidson lowered their price target on shares of USANA Health Sciences from $38.00 to $36.00 and set a "neutral" rating on the stock in a research report on Thursday, February 27th.
Read Our Latest Analysis on USNA
Insider Buying and Selling
In related news, CEO Jim Brown sold 5,000 shares of the company's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $29.47, for a total transaction of $147,350.00. Following the completion of the sale, the chief executive officer now directly owns 15,716 shares in the company, valued at $463,150.52. This represents a 24.14 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Joshua Foukas sold 5,732 shares of USANA Health Sciences stock in a transaction dated Wednesday, March 12th. The shares were sold at an average price of $32.54, for a total value of $186,519.28. The disclosure for this sale can be found here. Insiders sold 15,920 shares of company stock valued at $500,285 over the last quarter. 0.63% of the stock is owned by company insiders.
About USANA Health Sciences
(
Get Free Report)
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
See Also
Before you consider USANA Health Sciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and USANA Health Sciences wasn't on the list.
While USANA Health Sciences currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
